European Journal of Surgical Oncology
Volume 36, Issue 7 , Pages 646-651 , July 2010

Staging and management of axillary lymph nodes in patients with local recurrence in the breast or chest wall after a previous negative sentinel node procedure

  • F. Derkx

      Affiliations

    • Faculty of Health Medicine and Life Sciences, Maastricht University, P.O. Box 616, 6200 MD, Maastricht, The Netherlands
    • Corresponding Author InformationCorresponding author. Tel.: +31 43 3882387.
    • ,
  • A.J.G. Maaskant-Braat

      Affiliations

    • Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands
    • ,
  • M.J.C. van der Sangen

      Affiliations

    • Department of Radiotherapy, Catharina Hospital, Eindhoven, The Netherlands
    • ,
  • G.A.P. Nieuwenhuijzen

      Affiliations

    • Department of Surgery, Catharina Hospital, Eindhoven, The Netherlands
    • ,
  • L.V. van de Poll-Franse

      Affiliations

    • Eindhoven Cancer Registry, Eindhoven, The Netherlands
    • Corps – Centre of Research on Psychology in Somatic Diseases, Department of Medical Psychology, Tilburg University, The Netherlands
    • ,
  • R.M.H. Roumen

      Affiliations

    • Department of Surgery, Máxima Medical Centre, Veldhoven, The Netherlands
    • ,
  • A.C. Voogd

      Affiliations

    • Eindhoven Cancer Registry, Eindhoven, The Netherlands
    • Department of Epidemiology, Faculty of Health Medicine and Life Sciences, Research Institute Growth and Development (GROW), Maastricht University, Maastricht, The Netherlands

,Accepted 4 May 2010.

References 

  1. Roumen RM, Kuijt GP, Liem IH, van Beek MW. Treatment of 100 patients with sentinel node-negative breast cancer without further axillary dissection. Br J Surg. 2001;88:1639–1643
  2. Naik AM, Fey J, Gemignani M, et al. The risk of axillary relapse after sentinel node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg. 2004;240:462–468
  3. Veronesi U, Paganelli G, Viale G, et al. Sentinel-lymph-node biopsy as a staging procedure in breast cancer: update of a randomised controlled study. Lancet Oncol. 2006;7:983–990
  4. Voogd AC, Nielsen M, Peterse JL, et al. Differences in risk factors for local and distant recurrence after breast-conserving therapy of mastectomy for stage I and II breast cancer: pooled results of two large European randomized trials. J Clin Oncol. 2001;15:1688–1697
  5. Jacobsen JA, Danforth DN, Cowan KH, et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 1995;332:907–911
  6. Roumen RMH, Kuijt GP, Liem IH. Lymphatic mapping and sentinel node harvesting in patients with recurrent breast cancer. Eur J Surg Oncol. 2006;32:1076–1081
  7. Port ER, Garcia-Etienne CA, Park J, Fey J, Borgen PI, Cody HS. Reoperative sentinel lymph node biopsy: a new frontier in the management of ipsilateral breast tumor recurrence. Ann Surg Oncol. 2007;14:2209–2214
  8. Oncoline Oncological Guidelines . www.oncoline.nlAccessed 08.06.09
  9. Voogd AC, van Tienhoven G, Peterse HL, et al. Local recurrence after breast conservation therapy for early stage breast carcinoma: detection, treatment, and outcome in 266 patients. Dutch Study Group on Local Recurrence after Breast Conservation (BORST). Cancer. 1999;85:437–446
  10. Giuliano AE, Barth AM, Spivack B, Beitsch PD, Evans SW. Incidence and predictors of axillary metastasis in T1 carcinoma of the breast. J Am Coll Surg. 1996;183:262–264
  11. Borner M, Bacchi M, Goldhirsch A, et al. First isolated locoregional recurrence following mastectomy for breast cancer: results of a phase III multicenter study comparing systemic treatment with observation after excision and radiation. Swiss Group for Clinical Cancer Research. J Clin Oncol. 1994;12:2071–2077
  12. Haylock BJ, Coppin CM, Jackson J, Basco VE, Wilson KS. Locoregional first recurrence after mastectomy: prospective cohort studies with and without immediate chemotherapy. Int J Radiat Oncol Biol Phys. 2000;46:355–362
  13. Rauschecker H, Clarke M, Gatzemeier , Recht A. Systemic therapy for treating locoregional recurrence in women with breast cancer. Cochrane Database Syst Rev. 2001;4
  14. Aebi S, Wapnir I. A randomized clinical trial of adjuvant chemotherapy for radically resected loco-regional relapse of breast cancer. IBCSG 27–02/BIG 1-02 (BOOG 2003-02).
  15. Overgaard M, Jensen MB, Overgaard J, et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial. Lancet. 1999;353:1641–1648
  16. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med. 1997;337:949–955
  17. Ragaz J, Olivotto IA, Spinelli JJ, et al. Locoregional radiation therapy in patients with high-risk breast cancer receiving adjuvant chemotherapy: 20-year result of the British Columbia randomized trial. J Natl Cancer Inst. 2005;19:116–126
  18. Orr RK. The impact of prophylactic axillary node dissection on breast cancer survival – a Bayesian meta-analysis. Ann Surg Oncol. 1999;6:17–18
  19. Martelli G, Miceli R, Costa A, et al. Elderly breast cancer patients treated by conservative surgery alone plus adjuvant tamoxifen: fifteen-year results of a prospective study. Cancer. 2008;112:481–488
  20. Hughes KS, Schnaper LA, Berry D, et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med. 2004;351:971–977
  21. Wildiers H, Kunkler I, Biganzolli L, et al. Management of breast cancer in elderly individuals: recommendations of the International Society of Geriatric Oncology. Lancet Oncol. 2007;8:1101–1115
  22. Ververs JM, Roumen RM, Vingerhoets AJ, et al. Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer. 2001;37:991–999
  23. Schijven MP, Vingerhoets AJ, Rutten HJ, et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol. 2003;29:341–350
  24. Karam A, Stempel M, Cody HS, Port ER. Reoperative sentinel lymph node biopsy after previous mastectomy. J Am Coll Surg. 2008;207:543–548
  25. Cox CE, Furman BT, Kiluk JV, et al. Use of reoperative sentinel lymph node biopsy in breast cancer patients. J Am Coll Surg. 2008;207:57–61
  26. Intra M, Trifirò G, Galimberti V, Gentilini O, Rotmensz N, Veronesi P. Second axillary sentinel node biopsy for ipsilateral breast tumour recurrence. Br J Surg. 2007;94:1216–1219
  27. Povoski SP, Olsen JO, Young DC, et al. Prospective randomized clinical trial comparing intradermal, intraparenchymal, and subareolar injection routes for sentinel node mapping and biopsy in breast cancer. Ann Surg Oncol. 2006;13:1412–1421

PII: S0748-7983(10)00117-4

doi: 10.1016/j.ejso.2010.05.009

European Journal of Surgical Oncology
Volume 36, Issue 7 , Pages 646-651 , July 2010

Article Tools